CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

122 hedge funds and large institutions have $993M invested in Crinetics Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
–
Holders Change %
0%
% of All Funds
1.97%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
13
Increased
45
Reduced
37
Closed
13
Calls
$43K
Puts
$20K
Net Calls
+$23K
Net Calls Change
-$2.48M

Top Buyers

1
FC
1
Finepoint Capital
Massachusetts
$15.1M
2
PBA
2
Paradigm Biocapital Advisors
New York
$16.3M
3
Millennium Management
3
Millennium Management
New York
$10.5M
4
State Street
4
State Street
Massachusetts
$36.7M
5
Ensign Peak Advisors
5
Ensign Peak Advisors
Utah
$4.95M

Top Sellers

1
PA
1
Perceptive Advisors
New York
$73.9M
2
BI
2
BVF Inc
California
$50.1M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$34.5M
4
BBA
4
Baker Bros. Advisors
New York
$0
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$2.52M
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$10.5M +$4.64M +253,736 +79%
Northern Trust
27
Northern Trust
Illinois
$8.8M +$44.2K +2,418 +0.5%
Janus Henderson Group
28
Janus Henderson Group
United Kingdom
$7.43M +$486K +26,568 +7%
Walleye Capital
29
Walleye Capital
New York
$7.42M +$2.85M +155,545 +62%
MB
30
MPM BioImpact
Massachusetts
$6.8M +$127K +6,929 +2%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$6.44M +$188K +10,277 +3%
Charles Schwab
32
Charles Schwab
California
$6.28M +$126K +6,865 +2%
Ensign Peak Advisors
33
Ensign Peak Advisors
Utah
$4.95M +$3.26M +177,945 +193%
SCM
34
Silverarc Capital Management
Massachusetts
$2.8M +$68.1K +3,720 +2%
Morgan Stanley
35
Morgan Stanley
New York
$2.79M +$925K +50,556 +50%
First Manhattan
36
First Manhattan
New York
$2.79M – – –
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$2.74M – – –
NLVP
38
New Leaf Venture Partners
New York
$2.58M – – –
Nuveen Asset Management
39
Nuveen Asset Management
Illinois
$2.52M -$2.91M -158,898 -54%
Goldman Sachs
40
Goldman Sachs
New York
$2.44M +$195K +10,648 +9%
MPAM
41
Monarch Partners Asset Management
Massachusetts
$2.36M -$34.5K -1,886 -1%
Bank of America
42
Bank of America
North Carolina
$2.27M +$1.18M +64,610 +109%
Rafferty Asset Management
43
Rafferty Asset Management
New York
$1.95M +$568K +31,045 +41%
Two Sigma Advisers
44
Two Sigma Advisers
New York
$1.82M -$533K -29,100 -23%
HS
45
HighVista Strategies
Massachusetts
$1.72M +$33.8K +1,846 +2%
Swiss National Bank
46
Swiss National Bank
Switzerland
$1.66M +$51.2K +2,800 +3%
AI
47
Atom Investors
Texas
$1.49M +$596K +32,541 +67%
UBS Group
48
UBS Group
Switzerland
$1.48M +$1.33M +72,555 +891%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$1.45M -$128 -7 -0%
Fisher Asset Management
50
Fisher Asset Management
Washington
$1.41M +$431K +23,568 +44%
1
2
3 4 5